Global AI Pathology Analysis System Market Research Report 2025

Publication ID:

PB503250047

Publication Date:

March 3, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for AI Pathology Analysis System was valued at US$ 103 million in the year 2024 and is projected to reach a revised size of US$ 290 million by 2031, growing at a CAGR of 16.2% during the forecast period.
The AI 鈥嬧€媝athology analysis system is a medical diagnostic tool based on artificial intelligence technology. It automatically analyzes and identifies pathology slice images through deep learning algorithms, assisting pathologists in quickly and accurately detecting diseases such as cancer and inflammation. The system can extract features from massive pathology data, identify subtle lesions, and provide diagnostic suggestions, significantly improving diagnostic efficiency and accuracy while reducing human errors, providing strong support for precision medicine and personalized treatment.
North American market for AI Pathology Analysis System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Pathology Analysis System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI Pathology Analysis System in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Pathology Analysis System include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte, Qritive, Deepathology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI Pathology Analysis System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pathology Analysis System.
The AI Pathology Analysis System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Pathology Analysis System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Pathology Analysis System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics
Segment by Type
On-premises
Cloud-based
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Pathology Analysis System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Pathology Analysis System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 On-premises
1.2.3 Cloud-based
1.3 Market by Application
1.3.1 Global AI Pathology Analysis System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Pathology Analysis System Market Perspective (2020-2031)
2.2 Global AI Pathology Analysis System Growth Trends by Region
2.2.1 Global AI Pathology Analysis System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Pathology Analysis System Historic Market Size by Region (2020-2025)
2.2.3 AI Pathology Analysis System Forecasted Market Size by Region (2026-2031)
2.3 AI Pathology Analysis System Market Dynamics
2.3.1 AI Pathology Analysis System Industry Trends
2.3.2 AI Pathology Analysis System Market Drivers
2.3.3 AI Pathology Analysis System Market Challenges
2.3.4 AI Pathology Analysis System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Pathology Analysis System Players by Revenue
3.1.1 Global Top AI Pathology Analysis System Players by Revenue (2020-2025)
3.1.2 Global AI Pathology Analysis System Revenue Market Share by Players (2020-2025)
3.2 Global Top AI Pathology Analysis System Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Pathology Analysis System Revenue
3.4 Global AI Pathology Analysis System Market Concentration Ratio
3.4.1 Global AI Pathology Analysis System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Pathology Analysis System Revenue in 2024
3.5 Global Key Players of AI Pathology Analysis System Head office and Area Served
3.6 Global Key Players of AI Pathology Analysis System, Product and Application
3.7 Global Key Players of AI Pathology Analysis System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Pathology Analysis System Breakdown Data by Type
4.1 Global AI Pathology Analysis System Historic Market Size by Type (2020-2025)
4.2 Global AI Pathology Analysis System Forecasted Market Size by Type (2026-2031)
5 AI Pathology Analysis System Breakdown Data by Application
5.1 Global AI Pathology Analysis System Historic Market Size by Application (2020-2025)
5.2 Global AI Pathology Analysis System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Pathology Analysis System Market Size (2020-2031)
6.2 North America AI Pathology Analysis System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Pathology Analysis System Market Size by Country (2020-2025)
6.4 North America AI Pathology Analysis System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Pathology Analysis System Market Size (2020-2031)
7.2 Europe AI Pathology Analysis System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Pathology Analysis System Market Size by Country (2020-2025)
7.4 Europe AI Pathology Analysis System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Pathology Analysis System Market Size (2020-2031)
8.2 Asia-Pacific AI Pathology Analysis System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Pathology Analysis System Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Pathology Analysis System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Pathology Analysis System Market Size (2020-2031)
9.2 Latin America AI Pathology Analysis System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Pathology Analysis System Market Size by Country (2020-2025)
9.4 Latin America AI Pathology Analysis System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Pathology Analysis System Market Size (2020-2031)
10.2 Middle East & Africa AI Pathology Analysis System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Pathology Analysis System Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Pathology Analysis System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Visiopharm
11.1.1 Visiopharm Company Details
11.1.2 Visiopharm Business Overview
11.1.3 Visiopharm AI Pathology Analysis System Introduction
11.1.4 Visiopharm Revenue in AI Pathology Analysis System Business (2020-2025)
11.1.5 Visiopharm Recent Development
11.2 PathAI
11.2.1 PathAI Company Details
11.2.2 PathAI Business Overview
11.2.3 PathAI AI Pathology Analysis System Introduction
11.2.4 PathAI Revenue in AI Pathology Analysis System Business (2020-2025)
11.2.5 PathAI Recent Development
11.3 Aiforia
11.3.1 Aiforia Company Details
11.3.2 Aiforia Business Overview
11.3.3 Aiforia AI Pathology Analysis System Introduction
11.3.4 Aiforia Revenue in AI Pathology Analysis System Business (2020-2025)
11.3.5 Aiforia Recent Development
11.4 Indica Labs
11.4.1 Indica Labs Company Details
11.4.2 Indica Labs Business Overview
11.4.3 Indica Labs AI Pathology Analysis System Introduction
11.4.4 Indica Labs Revenue in AI Pathology Analysis System Business (2020-2025)
11.4.5 Indica Labs Recent Development
11.5 aetherAI
11.5.1 aetherAI Company Details
11.5.2 aetherAI Business Overview
11.5.3 aetherAI AI Pathology Analysis System Introduction
11.5.4 aetherAI Revenue in AI Pathology Analysis System Business (2020-2025)
11.5.5 aetherAI Recent Development
11.6 Proscia
11.6.1 Proscia Company Details
11.6.2 Proscia Business Overview
11.6.3 Proscia AI Pathology Analysis System Introduction
11.6.4 Proscia Revenue in AI Pathology Analysis System Business (2020-2025)
11.6.5 Proscia Recent Development
11.7 Mindpeak
11.7.1 Mindpeak Company Details
11.7.2 Mindpeak Business Overview
11.7.3 Mindpeak AI Pathology Analysis System Introduction
11.7.4 Mindpeak Revenue in AI Pathology Analysis System Business (2020-2025)
11.7.5 Mindpeak Recent Development
11.8 Techcyte
11.8.1 Techcyte Company Details
11.8.2 Techcyte Business Overview
11.8.3 Techcyte AI Pathology Analysis System Introduction
11.8.4 Techcyte Revenue in AI Pathology Analysis System Business (2020-2025)
11.8.5 Techcyte Recent Development
11.9 Qritive
11.9.1 Qritive Company Details
11.9.2 Qritive Business Overview
11.9.3 Qritive AI Pathology Analysis System Introduction
11.9.4 Qritive Revenue in AI Pathology Analysis System Business (2020-2025)
11.9.5 Qritive Recent Development
11.10 Deepathology
11.10.1 Deepathology Company Details
11.10.2 Deepathology Business Overview
11.10.3 Deepathology AI Pathology Analysis System Introduction
11.10.4 Deepathology Revenue in AI Pathology Analysis System Business (2020-2025)
11.10.5 Deepathology Recent Development
11.11 Franklin.ai
11.11.1 Franklin.ai Company Details
11.11.2 Franklin.ai Business Overview
11.11.3 Franklin.ai AI Pathology Analysis System Introduction
11.11.4 Franklin.ai Revenue in AI Pathology Analysis System Business (2020-2025)
11.11.5 Franklin.ai Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Details
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics AI Pathology Analysis System Introduction
11.12.4 Roche Diagnostics Revenue in AI Pathology Analysis System Business (2020-2025)
11.12.5 Roche Diagnostics Recent Development
11.13 Flagship
11.13.1 Flagship Company Details
11.13.2 Flagship Business Overview
11.13.3 Flagship AI Pathology Analysis System Introduction
11.13.4 Flagship Revenue in AI Pathology Analysis System Business (2020-2025)
11.13.5 Flagship Recent Development
11.14 Dedalus Group
11.14.1 Dedalus Group Company Details
11.14.2 Dedalus Group Business Overview
11.14.3 Dedalus Group AI Pathology Analysis System Introduction
11.14.4 Dedalus Group Revenue in AI Pathology Analysis System Business (2020-2025)
11.14.5 Dedalus Group Recent Development
11.15 Ibex Medical Analytics
11.15.1 Ibex Medical Analytics Company Details
11.15.2 Ibex Medical Analytics Business Overview
11.15.3 Ibex Medical Analytics AI Pathology Analysis System Introduction
11.15.4 Ibex Medical Analytics Revenue in AI Pathology Analysis System Business (2020-2025)
11.15.5 Ibex Medical Analytics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂